Regulation of osteogenic proteins by chondrocytes

International Journal of Biochemistry and Cell Biology

Volumn 35, Issue 9, 2003, Pages 1323-1340

  Chubinskaya, Susan ^a   Kuettner, Klaus E ^a  

^a RUSH MEDICAL COLLEGE   (United States)

Author keywords

Adult articular cartilage; Anabolic activity in vitro; Anabolic activity in vivo; Bone morphogenetic proteins; Endogenous expression; Gene modulation

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; OSTEOGENIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA;

ARTICULAR CARTILAGE; BIOSYNTHESIS; CARTILAGE CELL; CARTILAGE MATRIX; CATTLE; CELL FUNCTION; CHONDROPATHY; DATA ANALYSIS; DNA MODIFICATION; GOAT; HUMAN; INJURY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RABBIT; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TISSUE REPAIR;

ANIMALIA; BOVINAE; CAPRA HIRCUS; ORYCTOLAGUS CUNICULUS;

EID: 0038721179     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(03)00035-9     Document Type: Review

References (115)

1. Anderson H.C., Hodges P.T., Aguilera X.M., Missana L., Moylan P.E. Bone morphogenetic protein (BMP) localization in developing human and rat growth plate, metaphysis, epiphysis, and articular cartilage. Journal of Histochemistry and Cytochemistry. 48(11):2000;1493-1502.
2. Andrews H.J., Edwards T.A., Cawston T.E., Hazleman B.L. Transforming growth factor-β causes partial inhibition of interleukin-1-stimualted cartilage degradation in vitro. Biochemical and Biophysical Research Communications. 162(1):1989;144-150.
3. Aydelotte, M. B., Schumacher, B. L. & Kuettner, K. E. (1991). Heterogeneity of articular chondrocytes. In K. E. Kuettner, R. Schleyerbach, J. G. Peyron, & V. C. Hascall (Eds.), Articular Cartilage and Osteoarthritis (pp. 237-250). New York: Raven Press.
4. Aydelotte M.B., Mok S.S., Michal L., Häuselmann H.J. Effects of misoprostol with interleukin-1 on proteoglycan metabolism of cultured articular chondrocytes. American Journal of Therapeutics. 3:1996;3-8.
5. Blanco F.J., Geng Y., Lotz M. Differentiation-dependent effects of IL-1 and TGF-beta on human articular chondrocyte proliferation are related to inducible nitric oxide synthase expression. Journal of Immunology. 154(8):1995;4018-4026.
6. Bobacz K., Gruber R., Soleiman A., Graninger W.B., Luyten F.P., Erlacher L. Cartilage-derived morphogenetic protein-1 and -2 are endogenously expressed in health and osteoarthritic human articular chondrocytes and stimulate matrix synthesis. Osteoarthritis and Cartilage. 10:2002;394-401.
7. Brown T.D., Shaw D.T. In vitro contact stress distributions in the natural human hip. Biomechanics. 16:1983;373-384.
8. Chambers M.G., Bayliss M.T., Mason R.M. Chondrocyte cytokine and growth factor expression in murine osteoarthritis. Osteoarthritis and Cartilage. 5:1997;301-308.
9. Chandrasekhar S., Harvey A.K. Transforming growth factor-beta is a potent inhibitor of IL-1 induced protease activity and cartilage proteoglycan degradation. Biochemical and Biophysical Research Communications. 157(3):1988;1352-1359.
10. Chen P., Vukicevic S., Sampath T.K., Luyten F.P. Bovine articular chondrocytes do not undergo hypertrophy when cultured in the presence of serum and osteogenic protein-1. Biochemical and Biophysical Research Communications. 197(3):1993;1253-1259.
11. Chubinskaya, S., Kuettner, K. E. (2002). Exogenous and endogenous OP-1 in articular cartilage. In T. Lindholm (Ed.), Advances in skeletal reconstruction using bone morphogenetic proteins (pp. 157-183). Singapore: World Scientific.
12. Chubinskaya S., Kumar B., Merrihew C., Heretis K., Rueger D.C., Kuettner K.E. Age-related changes in cartilage endogenous OP-1: New ELISA method. Biochimica et Biophysica Acta - Molecular Basis of Disease. 1588(2):2002;126-134.
13. Chubinskaya S., Merrihew C., Cs-Szabo G., Mollenhauer J., McCartney J., Rueger D.C., Kuettner K.E. Human articular chondrocytes express osteogenic protein. Journal of Histochemistry and Cytochemistry. 48(2):2000;239-250.
14. Chubinskaya, S., Smith, A., Hakimiyan, A., Pacione, C., Rueger, D., Loeser, R.F., 2002. Synergistic effect of IGF-1 and OP-1 on matrix formation by normal and OA chondrocytes cultured in alginate beads. In Proceedings of the 4th ICRS Symposium (abstract), Toronto, 15-18 June.
15. Cook S.D., Rueger D.C. Osteogenic protein-1. Biology and applications. Clinical Orthopaedics. 324:1996;29-38.
16. Dingle J.T. Cartilage maintenance in osteoarthritis: interaction of cytokines, NSAID and prostaglandins in articular cartilage damage and repair. Journal of Rheumatology. 28:1991;30-37.
17. Dudley A.T., Lyons K.M., Robertson E.J. A requirement for bone morphogenetic protein 7 during development of the mammalian eye. Genes Development. 9:1995;2795-2807.
18. Duprez D., Bell E.J., Richardson M.K., Archer C.W., Wolpert L., Brickell P.M., Francis-West P.H. Overexpression of BMP-2 and BMP-4 alters the size and shape of developing skeletal elements in the chick limb. Mechanical Development. 57:1996;145-157.
19. Elford P.R., Graeber M., Ohtsu H., Aeberhard M., Legendre B., Wishart W.L., MacKenzie A.R. Induction of swelling. Cytokine. 4(3):1992;232-238.
20. Erlacher L., Ng C.-K., Ullrich R., Krieger S., Luyten F.P. Presence of cartilage-derived morphogenetic proteins in articular cartilage and enhancement of matrix replacement in vitro. Arthritis and Rheumatism. 41:1998;263-273.
21. Felson, D. T., 1995. The epidemiology of osteoarthritis: prevalence and risk factors. In K. E. Kuettner, & V. M. Goldberg, (Eds.), Osteoarthritic disorders (pp. 13-24). Rosemont, IL (USA): American Academy of Orthopaedic Surgeons.
22. Flechtenmacher J., Huch K., Thonar E.J.-M.A., Mollenhauer J.A., Davies S.R., Schmid T.M., Puhl W., Sampath T.K., Aydelotte M.B., Kuettner K.E. Recombinant human osteogenic protein 1 is a potent stimulator of the synthesis of cartilage proteoglycans and collagens by human articular chondrocytes. Arthritis and Rheumatism. 39:1996;1896-1904.
23. Frenkel S., Saadeh P., Mehrara B., Chin G.S., Steinbrech D., Brent B., Gittes G., Longaker M. Transforming growth factor beta superfamily members: role in cartilage modeling. Plastic and Reconstructive Surgery. 105(3):2000;980-990.
24. Galera P., Vivien D., Pronost S., Bonaventure J., Redini F., Loyau G., Pujol J.P. Transforming growth factor-β1 (TGF-β1) up-regulation of collagen type II in primary cultures of rabbit articular chondrocytes involves increased mRNA levels without affecting mRNA stability and procollagen processing. Journal of Cell Physiology. 153:1992;596-606.
25. Ganan Y., Macias D., Duterque-Coquillaud M., Ros M.A., Hurle J.M. Role of TGF-βs and BMPs as signals controlling the position of the digits and areas of interdigital cell death in the developing chick limb bud autopod. Development. 122:1996;2349-2357.
26. Gigante, A., Chillemi, C., Greco, F. (2002). BMPs in the repair of articular cartilage lesions: experimental studies and clinical application. In T. Lindholm (Ed.), Advances in skeletal reconstruction using bone morphogenetic protein (pp. 204-223). Singapore: World Scientific.
27. Glansbeek H.L., van Beuningen H.M., Vitters E.L., Morris E.A., van der Kraan P.M., van den Berg W.B. Bone morphogenetic protein-2 stimulates articular cartilage proteoglycan synthesis in vivo but does not counteract interleukin-1 alpha effects on proteoglycan synthesis and content. Arthritis and Rheumatism. 40(6):1997;1020-1028.
28. Glansbeek H.L., van der Kraan P.M., Vitters E.L., van den Berg W.B. Correlation of the size of type II transforming growth factor β (TGF-β) receptor with TGF-β responses of isolated bovine articular chondrocytes. Annals of the Rheumatic Diseases. 52:1993;812-816.
29. Grgic M., Jelic M., Basic V., Basic N., Pecina M., Vukicevic S. Regeneration of articular cartilage defects in rabbits by osteogenic protein-1 (bone morphogenetic protein-7). Acta Medica Croatia. 51:1997;23-27.
30. Griffith D.L., Keck P.C., Sampath T.K., Rueger D.C., Carlson W.D. Three-dimensional structure of recombinant human osteogenic protein 1: structural paradigm for the transforming growth factor β superfamily. Proceedings of the National Academy of Sciences of the United States of America. 93:1996;878-883.
31. Grodzinsky, A.J., Kim, Y.J., Buschmann, M.D., Quinn, T.M., Garcia, A.M., & Hunziker, E.B. (1998). Response of the chondrocyte to mechanical stimuli. In K. D. Brandt, M. Doherty & L. S. Lohmander (Eds.), Osteoarthritis (pp. 123-136). Oxford: Oxford University Press.
32. Hardingham T.E., Bayliss M.T., Rayan V., Noble D.P. Effects of growth factors and cytokines on proteoglycans turnover in articular cartilage. British Journal of Rheumatology. 31:1992;1-6.
33. Harvey A.K., Hrubey P.S., Chandrasekhar S. Transforming growth factor-β inhibition of interleukin-1 activity involves down-regulation of interleukin-1 receptors on chondrocytes. Experimental Cell Research. 195:1991;376-385.
34. Heyligers, I. C., Klein-Nulend, J., Burger, E. H. (2002). Use of recombinant OP-1 in cartilage repair - in vitro and in vivo studies. In T. Lindholm (Ed), Advances in skeletal reconstruction using bone morphogenetic proteins (pp. 184-203). Singapore: World Scientific.
35. Hidaka C., Quitoriano M., Warren R.F., Crystal R.G. Enhanced matrix synthesis and in vitro formation of cartilage-like tissue by genetically modified chondrocytes expressing BMP-7. Journal of Orthopaedic Research. 19:2001;751-758.
36. Hogan B.L.M. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes & Development. 10:1996;1580-1594.
37. Homandberg G.A., Hui F., Wen C. Cartilage damaging activities of fibronectin fragments derived from cartilage and synovial fluids. Osteoarthritis and Cartilage. 6:1998;231-244.
38. Huch K., Wilbrink B., Flechtenmacher J., Koepp H.E., Aydelotte M.B., Sampath T.K., Kuettner K.E., Mollenhauer J.A., Thonar E.J.-M.A. Effects of recombinant human osteogenic protein 1 on the production of proteoglycan, prostaglandin E2, and interleukin-1 receptor antagonist by human articular chondrocytes cultured in the presence of interleukin-1β Arthritis and Rheumatism. 40:1997;2157-2161.
39. Hunziker, E. B. (1991). Articular cartilage structure in humans and experimental animals. In K. E. Kuettner, R. Schleyerbach, J. G. Peyron, & V. C. Hascall (Eds.), Articular cartilage and osteoarthritis (pp. 237-249). New York: Raven Press.
40. Hunziker E.B. Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. Osteoarthritis and Cartilage. 10:2001;432-463.
41. Hunziker E.B. Growth-factor-induced healing of partial-thickness defects in adult articular cartilage. Osteoarthritis and Cartilage. 9:2001;22-32.
42. Jennings L., Madsen L., Mollenhauer J.A. The effect of collagen fragments on the extracellular matrix metabolism of bovine and human chondrocytes. Connective Tissue Research. 42(1):2001;71-86.
43. Jones W.K., Richmond E.A., White K., Sasak H., Kusmik W., Smart J., Oppermann H., Rueger D.C., Tucker R.F. Osteogenic protein-1 expression and processing in Chinese Hamster Ovary cells: isolation of a soluble complex containing the mature and pro-domains of OP-1. Growth Factors. 11(3):1994;215-225.
44. Kaps C., Bramlage C., Smolian H., Haisch A., Ungethum U., Burmester G.-R., Sittinger M., Gross G., Haupl T. Bone morphogenetic proteins promote cartilage differentiation and protect engineered artificial cartilage from fibroblast invasion and destruction. Arthritis and Rheumatism. 46:2002;149-162.
45. King J.A., Marker P.C., Seung K.J., Kingsley D.M. BMP-5 and molecular, skeletal and soft tissue alterations in short ear mice. Developmental Biology. 166:1994;112-122.
46. Kingsley D.M., Bland A.E., Grubber J.M., Marker P.C., Russell L.B., Copeland N.G., Jenkins N.A. The mouse short ear skeletal morphogenesis locus is associated with defects in a bone morphogenetic protein member of the TGF-β superfamily. Cell. 71:1992;399-410.
47. Knudson W., Casey B., Nishida Y., Eger W., Kuettner K.E., Knudson C.B. Hyaluronan oligosaccharides perturb cartilage matrix homeostasis and induce cartilage chondrolysis. Arthritis and Rheumatism. 43:2000;1165-1174.
48. Koepp H.E., Sampath K.T., Kuettner K.E., Homandberg G.A. Osteogenic protein-1 (OP-1) blocks cartilage damage caused by fibronectin fragments and promotes repair by enhancing proteoglycan synthesis. Inflammation and Research. 47:1999;1-6.
49. Kuettner K.E., Aydelotte M.B., Thonar E.J.-M.A. Articular cartilage matrix and structure: a minireview. Journal of Rheumatology. 18(Suppl 27):1991;46-48.
50. Lafeber F.P.J.G., van der Kraan P.M., Huber-Bruning O., van den Berg W.B., Bijlsma J.W.J. Osteoarthritic human cartilage is more sensitive to transforming growth factor β than normal cartilage. British Journal of Rheumatology. 32:1993;281-286.
51. Lafeber F.P.J.G., van Roy H.L.A.M., van der Kraan P.M., van den Berg W.B., Bijlsma J.W.J. Transforming growth factor-β predominantly stimulates phenotypically changed chondrocytes in osteoarthritic human cartilage. Journal of Rheumatism. 24:1997;536-542.
52. 1 integrin in the modulation by collagen of chondrocytes-response to transforming growth factor-β1. Journal of Orthopaedic Research. 20:2002;66-75.
53. Lietman S., Yanagishita M., Sampath T.K., Reddi A.H. Stimulation of proteoglycan synthesis in explants of porcine articular cartilage by recombinant osteogenic protein-1 (bone morphogenetic protein-7). Journal of Bone and Joint Surgery. 79-A:1997;1132-1137.
54. Louwerse R.T., Heyligers I.C., Klein-Nulend J., Sugihara S., van Kampen G.P., Semeins C.M., Goei S.W., Koning M.H., Wuisman P.I., Burger E.H. Use of recombinant human osteogenic protein-1 for the repair of subchondral defects in articular cartilage in goats. Journal of Biomedical Materials Research. 49(4):2000;506-516.
55. Luo G., Hofmann C., Bronckers A.L.J.J., Sohocki M., Bradley A., Karsenty G. BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Development. 9:1995;2808-2820.
56. Luyten F.P., Yu Y.M., Yanagishita M., Vukicevic S., Hammonds R.G., Reddi A.H. Natural bovine osteogenin and recombinant human bone morphogenetic protein-2B are equipotent in the maintenance of proteoglycans in bovine articular cartilage explant culture. Journal of Biological Chemistry. 267:1992;3691-3695.
57. Luyten F.P., Chen P., Paralkar V., Reddi A.H. Recombinant bone morphogenetic protein-4, transforming growth factor-β, and activin A enhance the cartilage phenotype of articular chondrocytes in vitro. Experimental Cell Research. 210:1994;224-229.
58. Manicourt D.H., Thonar E.J.-M.A., Pita J.C., Howell D.S. Changes in segmentation profile of proteoglycan aggregates in early experimental canine osteoarthritis. Connective Tissue Research. 23(1):1989;33-50.
59. Maroudas, A., Schneiderman, R., Popper & O. (1991). The role of water, proteoglycan, and collagen in solute transport in cartilage. In K. E. Kuettner, R. Schleyerbach, J. G. Peyron, & V. C. Hascall (Eds.), Articular cartilage and osteoarthritis (pp. 355-372). New York: Raven Press.
60. Mason J., Breitbart A.S., Barcia M., Porti D., Pergolizzi R.G., Grande D.A. Cartilage and bone regeneration using gene-enhanced tissue engineering. Clinical Orthopaedics. 1(Suppl.):2000;S171-S178.
61. Mattioli-Belmonte M., Gigante A., Muzzarelli R.A., Politano R., De Benedittis A., Specchia N., Buffa A., Biagini G., Greco F. N,N-dicarboxymethyl chitosan as delivery agent for bone morphogenetic protein in the repair of articular cartilage. Medical and Biological Engineering and Computing. 37:1999;130-134.
62. Merrihew C., Soeder S., Rueger D.C., Kuettner K.E., Chubinskaya S. Response of osteogenic protein-1 to interleukin-1 in human knee articular cartilage (abstract). Transactions of the Orthopaedic Research Society. 48:2002;193.
63. Morales T.I., Roberts A.B. Transforming growth factor-β regulates the metabolism of proteoglycans in bovine cartilage organ cultures. Journal of Biological Chemistry. 263:1988;12828-12831.
64. Morris E. Differential effects of TGF-beta superfamily members on articular cartilage metabolism: stimulation by rhBMP-9 and rhBMP-2 and inhibition by TGF-beta (abstract). Transactions of the Orthopaedic Research Society. 42:1996;175.
65. Mow V.C., Ateshian G.A., Spilker R.L. Biomechanics of diarthrodial joints: a review of twenty years of progress. Journal of Biomechanical Engineering. 115:1993;460-467.
66. Muehleman C., Kuettner K.E., Rueger D.C., ten Dijke P., Chubinskaya S. Immunohistochemical localization of osteogenic protein (OP-1) and its receptors in rabbit articular cartilage. Journal of Histochemistry and Cytochemistry. 50:2002;1341-13509.
67. Nishida Y., Knudson C.B., Kuettner K.E., Knudson W. Osteogenic protein-1 promotes the synthesis and retention of extracellular matrix within bovine articular cartilage and chondrocyte cultures. Osteoarthritis and Cartilage. 8:2000;127-136.
68. Nishida Y., Knudson C.B., Eger W., Kuettner K.E., Knudson W. Osteogenic protein-1 stimulates cell-associated matrix assembly by normal human articular chondrocytes: upregulation of hyaluronan synthase. Arthritis and Rheumatism. 43:2000;206-214.
69. Ollivierre F., Gubler U., Towle C.A., Laurencin C., Treadwell B.V. Expression of IL-1 genes in human and bovine chondrocytes: a mechanism for autocrine control of cartilage matrix degradation. Biochemical and Biophysical Research Communications. 141:1986;904-911.
70. Pelletier J.P., McCollum R., Cloutier J.M., Martel-Pelletier P.J. Synthesis of metalloproteinases and interleukin 6 (IL-6) in human osteoarthritic synovial membrane is an IL-1 mediated process. Journal of Rheumatology. 22(43):1995;109-114.
71. Piek E., Heldin C.-H., ten Dijke P. Specificity, diversity, and regulation in TGF-β superfamily signaling. FACEB Journal. 13:1999;2105-2123.
72. Poole A.R., Rizkalla G., Ionescu M., Reiner A., Brooks E., Rorabeck C., Bourne R., Bogoch E. Osteoarthritis in the human knee: a dynamic process of cartilage matrix degradation. Agents and Actions. 39s:1993;3-13.
73. Poole, A. R. (1995). Imbalance of anabolism and catabolism of cartilage matrix components in osteoarthritis. In K. E. Kuettner, & V. M. Goldberg (Eds.), Osteoarthritic disorders (pp. 247-260). Rosemont, IL (USA): American Academy of Orthopaedic Surgeons.
74. Qi W.-N., Scully S.P. Extracellular collagen regulates expression of transforming growth factor-β1 gene. Journal of Orthopaedic Research. 18:2000;928-932.
75. Reddi A.H. Bone and cartilage differentiation. Current Opinion in Genetics and Development. 4:1994;937-944.
76. Redini F., Mauviel M., Galera P., Loyau G., Pujol J.P. Characterization of proteoglycans synthesized by rabbit articular chondrocytes in response to TGF-β Biochimica et Biophysica Acta. 1093:1991;196-206.
77. Rosen, V., Cox, K. & Hattersley, G. (1996). Bone morphogenetic proteins. In J. P. Belizikian, J. G. Raisz, & G. A. Rodan, (Eds.), Principles of bone biology (pp. 661-671). New York: Academic Press.
78. Sah, R. L.-Y., Grodzinsky, A. J., Plaas, A. H. K., & Sandy, J. D. (1991). Effects of static and dynamic compression on matrix metabolism in cartilage explants. In K. E. Kuettner, R. Schleyerbach, J. G. Peyron, & V. C. Hascall (Eds.), Articular cartilage and osteoarthritis (pp. 373-392). New York: Raven Press.
79. Sailor L.Z., Hewick R.M., Morris E.A. Recombinant human bone morphogenetic protein-2 maintains the articular chondrocyte phenotype in long-term culture. Journal of Orthopaedic Research. 14:1996;937-945.
80. Sampath T.K., Reddi A.H. Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. Proceedings of the National Academy of Sciences of the United States of America. 78:1981;7599-7603.
81. Sellers R., Peluso D., Morris E. The effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on the healing of full-thickness defects of articular cartilage. Journal of Bone and Joint Surgery. 79-A(10):1997;1452-1463.
82. Sellers R., Zhang R., Glasson S., Kim H., Peluso D., D'Augusta D., Beckwith K., Morris E. Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 (rhBMP-2). Journal of Bone and Joint Surgery. 82-A(2):2000;151-160.
83. Shlopov B.V., Smith G.N., Cole A.A., Hasty K.A. Differential patterns of response to doxycycline and transforming growth factor β1 in the down-regulation of collagenases of osteoarthritic and normal human chondrocytes. Arthritis and Rheumatism. 42:1999;719-727.
84. Smith P., Shuler F.D., Georgescu H.I., Ghivizzani S.C., Johnstone B., Niyibizi C., Robbins P.D., Evans C.H. Genetic enhancement of matrix synthesis by articular chondrocytes: comparison of different growth factor genes in the presence and absence of interleukin-1. Arthritis and Rheumatism. 43:2000;1156-1164.
85. Stewart M.C., Saunders K.M., Burton-Wurster N., Macleod J.N. Phenotypic stability of articular chondrocytes in vitro: the effect of culture models, bone morphogenetic protein 2, and serum supplementation. Journal of Bone and Mineral Research. 15:2000;166-174.
86. Storm E.E., Huynth T.V., Copeland N.G., Jenkins N.A., Kingsley D.M., Lee S.J. Limb alterations in brachypodism mice due to mutations in a new member of the TGF-β superfamily. Nature. 368:1994;639-642.
87. Studer R.K., Georgescu H.I., Miller L.A., Evans C.H. Inhibition of transforming growth factor β by nitric oxide-treated chondrocytes. Arthritis and Rheumatism. 42:1999;248-257.
88. Thompson C.C.M., Clegg P.D., Carter S.D. Differential regulation of gelatinases by transforming growth factor beta-1 in normal equine chondrocytes. Osteoarthritis and Cartilage. 9:2001;325-331.
89. Thonar, E. J.-M. A., Kuettner, K. E., & Williams, J. M. (1994). Markers of articular cartilage injury and healing. In J. T. Andrish (Ed.), Sports medicine and arthroscopy review: chondral injuries, vol. 2 (pp. 13-20). New York: Raven Press.
90. Urban, J., & Hall, A. (1991). Physical modifiers of cartilage metabolism. In K. E. Kuettner, R. Schleyerbach, J. G. Peyron, & V. C. Hascall (Eds.), Articular cartilage and osteoarthritis (pp. 393-406). New York: Raven Press.
91. Urist M.R., Mikulski A., Lietze A. Solubilized and insolubilized bone morphogenetic protein. Proceedings of the National Academy of Sciences of the United States of America. 76:1979;1828-1832.
92. Urist M.R. Bone morphogenetic protein: the molecularization of skeletal system development. Journal of Bone and Mineral Research. 12(3):1997;343-346.
93. van Beuningen H.M., van der Kraan P.M., Arntz O.J., van den Berg W.B. Protection from intereleukin1 induced destruction of articular cartilage by transforming growth factor β studies in anatomically intact cartilage in vitro and in vivo. Annals of the Rheumatic Diseases. 52:1993;185-191.
94. van Beuningen H.M., Glansbeek H.L., van der Kraan P.M., van den Berg W.B. Differential effects of local application of BMP-2 or TGF-β on both articular cartilage composition and osteophyte formation. Osteoarthritis and Cartilage. 6:1998;306-317.
95. van Beuningen H.M., Glansbeek H.L., van der Kraan P.M., van den Berg W.B. Osteoarthritis-like changes in the murine knee joint resulting from intra-articular transforming growth factor-β injections. Osteoarthritis and Cartilage. 8:2000;25-33.
96. van den Berg W.B., van der Kraan P.M., Scharstuhl A., van Beuningen H.M. Tissue engineering, cells, scaffolds, and growth factors: growth factors and cartilage. Clinical Orthopaedics and Related Research. S391:2001;S244-S250.
97. Van der Kraan P.M., Vitters E.L., van der Berg W.B. Inhibition of proteoglycan synthesis by TGFβ in anatomically intact articular cartilage. Annals of the Rheumatic Diseases. 51:1992;643-647.
98. van der Kraan P.M., Vitters E.L., van Beuningen H.M., van de Loo F.A.J., van den Berg W.B. Role of nitric oxide in the inhibition of BMP-2-mediated stimulation of proteoglycan synthesis in articular cartilage. Osteoarthritis and Cartilage. 8:2000;82-86.
99. van Susante J.L.C., Buma P., van Beuningen H.M., van den Berg W.B., Veth R.P.H. Responsiveness of bovine chondrocytes to growth factors in medium with different serum concentrations. Journal of Orthopaedic Research. 18:2000;68-77.
100. Vandenberg W.B., Vanosch G.J.V.M., Vanderkraan P.M., Vanbeuningen H.M. Cartilage destruction and osteophytes in instability-induced murine osteoarthritis-role of TGF beta in osteophyte formation. Agents and Actions. 40:1993;215-219.
101. Venn G., Billingham M.E., Hardingham T.E. Increased proteoglycan synthesis in cartilage in experimental canine osteoarthritis does not reflect a permanent change in chondrocyte phenotype. Arthritis and Rheumatism. 38(4):1995;525-532.
102. Villiger P.M., Lotz M. Differential expression of TGF-β isoforms by human articular chondrocytes in response to growth factors. Journal of Cell Physiology. 151:1992;318-325.
103. Villiger P.M., Kusari A.B., ten Dijke P., Lotz M. IL-1β and IL-6 selectively induce transforming growth factor-β isoforms in human articular chondrocytes. Journal of Immunology. 151(6):1993;3337-3344.
104. Vinall R.L., Lo S.H., Reddi A.H. Regulation of articular chondrocyte phenotype by bone morphogenetic protein 7, interleukin 1, and cellular context is dependent on the cytoskeleton. Experimental Cell Research. 272:2002;32-44.
105. Von den Hoff, De Koning, M. H., Van Kampen, G. P., Korst, J. K. (1994). TGFβ stimulates retinoic acid-induced proteoglycan depletion in intact articular cartilage. Archives of Biochemistry and Biophysics, 313, 241-247.
106. Vukicevic S., Luyten F.P., Reddi A.H. Stimulation of the expression of osteogenic and chondrogenic phenotypes in vitro by osteogenin. Proceedings of the National Academy of Sciences of the United States of America. 86:1989;8793-8797.
107. Wahl S.M., Costa G.L., Corcoran M., Wahl L.M., Berger A.E. Transforming growth factor-β mediates IL-1-dependent induction of IL-1 receptor antagonist. Journal of Immunology. 150:1993;3553-3560.
108. Weisser J., Rahfoth B., Timmermann A., Aigner T., Bräuer R., von der Mark K. Role of growth factors in rabbit articular cartilage repair by chondrocytes in agarose. Osteoarthritis and Cartilage. 9A:2001;S48-S54.
109. Winnier G., Blessing M., Labosky P.A., Hogan B.L. Bone morphogenetic protein 4 is required for mesoderm formation and patterning in the mouse. Genes Development. 9:1995;2105-2116.
110. Wozney J.M., Rosen V. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clinical Orthopaedics. 346:1998;26-37.
111. Wozney J.M., Rosen V., Celeste A.J., Mitsock L.M., Whitters M.J., Kriz R.W., Hewick R.M., Wang E.A. Novel regulators of bone formation: molecular clones and activities. Science. 242:1988;1528-1534.
112. Yao J., Cole A.A., Huch K., Kuettner K.E. The effect of OP-1 on IL-1beta induced gene expressions of matrix metalloproteinases and TIMP in human articular cartilage (abstract). Transactions of Orthopaedic Research Society. 42:1996;305.
113. Yeh L.C., Mallein-Gerin F., Lee J.C. Differential effects of osteogenic protein-1 (BMP-7) on gene expression of BMP and GDF family members during differentiation of the mouse MC615 chondrocyte cells. Journal of Cell Physiology. 191(3):2002;298-309.
114. Zhang H., Bradley A. Mice deficient for BMP-2 are nonviable and have defects in amnion/chorion and cardiac development. Development. 122:1996;2977-2986.
115. Zou H., Niswander L. Requirement for BMP signaling in interdigital apoptosis and scale formation. Science. 272:1996;738-741.